FDA Rounded out 2019 by Approving a New Treatment for Pancreatic Cancer
In the final days of 2019, the U.S. Food and Drug Administration (FDA) expanded the use of a previously...
In the final days of 2019, the U.S. Food and Drug Administration (FDA) expanded the use of a previously...
On Wednesday, the U.S. Food and Drug Administration (FDA) expanded the use of the molecularly targeted therapeutic niraparib (Zejula)...